Literature DB >> 19816063

The role of neurotrophins in the regulation of myelin development.

Junhua Xiao1, Trevor J Kilpatrick, Simon S Murray.   

Abstract

Neurotrophins comprise a family of growth factors that are expressed in a variety of cell types, and which exert influences on a large range of cellular activities that are important for development and the maintenance of the nervous system, as well as in neurodegenerative and psychiatric disorders. More recently, neurotrophins have been implicated in influencing the dynamic and complex signals that occur between neurons and glial cells, including Schwann cells in the peripheral nervous system and oligodendrocytes in the central nervous system that regulate myelination. Here we review the recent studies that identify neurotrophins as important regulators of both peripheral and central myelination, highlight some of the many questions that remain to be answered, and identify possibilities for further research. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816063     DOI: 10.1159/000231893

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  20 in total

1.  Motoneuron expression profiling identifies an association between an axonal splice variant of HDGF-related protein 3 and peripheral myelination.

Authors:  Bilal Ersen Kerman; Stéphane Genoud; Burcu Kurt Vatandaslar; Ahmet Murat Denli; Shereen Georges Ghosh; Xiangdong Xu; Gene W Yeo; James Bradley Aimone; Fred H Gage
Journal:  J Biol Chem       Date:  2020-07-09       Impact factor: 5.157

Review 2.  Promoting myelin repair and return of function in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Linnea Asp; Dipankar J Dutta; Kristina Navrazhina; Trinh Pham; John N Mariani; Azeb Tadesse Argaw; Carmen V Melendez-Vasquez; Gareth R John
Journal:  FEBS Lett       Date:  2011-08-18       Impact factor: 4.124

Review 3.  Targeting oligodendrocyte protection and remyelination in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Sean Mahase; Dipankar J Dutta; Virginie Bonnamain; Azeb T Argaw; Gareth R John
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

4.  Mesenchymal progenitor cells derived from traumatized muscle enhance neurite growth.

Authors:  Wesley M Jackson; Peter G Alexander; Jamie D Bulken-Hoover; Jared A Vogler; Youngmi Ji; Patricia McKay; Leon J Nesti; Rocky S Tuan
Journal:  J Tissue Eng Regen Med       Date:  2012-05-03       Impact factor: 3.963

5.  Neurotrophin treatment to promote regeneration after traumatic CNS injury.

Authors:  Lakshmi Kelamangalath; George M Smith
Journal:  Front Biol (Beijing)       Date:  2013-10-01

6.  Transient lysosomal activation is essential for p75 nerve growth factor receptor expression in myelinated Schwann cells during Wallerian degeneration.

Authors:  Junyang Jung; Wenting Cai; So Young Jang; Yoon Kyoung Shin; Duk Joon Suh; Jong Kuk Kim; Hwan Tae Park
Journal:  Anat Cell Biol       Date:  2011-03-31

7.  An orthopedic-, surgical-, and epidemiological-based investigation of leprosy, in the Tamil Nadu state of India.

Authors:  Jason Samona; Scott Samona; Cameron Samona; S Gopalakrishnan; P Shekhar; D Kubern; P S Mohan Kumar; Reza Nassiri
Journal:  Adv Orthop       Date:  2012-05-17

8.  Intrinsic and extrinsic regulators of oligodendrocyte progenitor proliferation and differentiation.

Authors:  Katrina L Adams; Kristin D Dahl; Vittorio Gallo; Wendy B Macklin
Journal:  Semin Cell Dev Biol       Date:  2020-10-22       Impact factor: 7.499

9.  How a common variant in the growth factor receptor gene, NTRK1, affects white matter.

Authors:  Meredith N Braskie; Neda Jahanshad; Arthur W Toga; Katie L McMahon; Greig I de Zubicaray; Nicholas G Martin; Margaret J Wright; Paul M Thompson
Journal:  Bioarchitecture       Date:  2012-09-01

10.  Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.

Authors:  Yi Pang; Baoying Zheng; Simpson L Kimberly; Zhengwei Cai; Philip G Rhodes; Rick C S Lin
Journal:  Brain Behav       Date:  2012-01       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.